Black Friday: 20% off all orders with code BLACK20.

Peptide Vials

NAD+ 1000mg Vial

$102.00

NAD+ 10 mL Vial

The Science, Simplified: NAD+ (nicotinamide adenine dinucleotide, oxidized form) is a critical coenzyme involved in cellular redox reactions and energy metabolism, supplied here as a research-grade liquid for laboratory use.

Product Specifications – NAD+ 10 mL Vial (1000 mg)

  • Total NAD+: 1000 mg
  • Volume: 10 mL vial
  • Concentration: 100 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use liquid vial

Key Research Focus: Applied in redox enzymology, sirtuin cofactor assays, and cellular energetics model systems requiring a high-concentration NAD+ stock.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Stability & Handling Notes:

  • Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.
  • For lyophilized orders please contact us (minimum order required)
    https://www.palmbeach-vitality.com

NAD+ 1000 mg / 10 mL (100 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.

How Labs Use This Format: Labs pipette at 100 mg/mL from this ready-to-use liquid vial when high total NAD+ content supports extended assay series. NAD pens may be available in the peptide pens category for dial-oriented workflows.

Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.

NAD+ Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the NAD+ research overview

  1. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+PubMed 31572171
  2. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world settingPubMed 41704678
  3. Clinical Evidence for Targeting NAD TherapeuticallyPubMed 32942582
  4. Roles of NAD+ in Health and AgingPubMed 37848251
  5. NAD+ therapy in age-related degenerative disorders: a benefit/risk analysisPubMed 31917996
NAD+ — dinucleotide structure
NAD+ — dinucleotide structure